Clinical Trial Update: Trial of an Intervention to Improve Metformin Persistence and Adherence [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating an intervention to improve metformin persistence and adherence; study completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metformin-related Adverse Reactions
• Type 2 Diabetes Mellitus

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Metformin Adverse Reaction, Tolerance | Phase 4 | Status: COMPLETED | Results posted: 2020-12-07